ARTICLE | Clinical News
P483 Techtide: Phase II trials
October 7, 1996 7:00 AM UTC
Diatide Inc. (DITI), Londonderry, N.H. Product: P483 Techtide imaging agent comprised of peptides linked to technetium-99m Use: Image internal infection Status: DITI began Phase II trials in 30 patien...